Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 287

1.

The interaction between cognition and motor control: A theoretical framework for dual-task interference effects on posture, gait initiation, gait and turning.

Bayot M, Dujardin K, Tard C, Defebvre L, Bonnet CT, Allart E, Delval A.

Neurophysiol Clin. 2018 Dec;48(6):361-375. doi: 10.1016/j.neucli.2018.10.003. Epub 2018 Oct 26. Review.

PMID:
30487064
2.

Suggestive association between OPRM1 and impulse control disorders in Parkinson's disease.

Cormier-Dequaire F, Bekadar S, Anheim M, Lebbah S, Pelissolo A, Krack P, Lacomblez L, Lhommée E, Castrioto A, Azulay JP, Defebvre L, Kreisler A, Durif F, Marques-Raquel A, Brefel-Courbon C, Grabli D, Roze E, Llorca PM, Ory-Magne F, Benatru I, Ansquer S, Maltête D, Tir M, Krystkowiak P, Tranchant C, Lagha-Boukbiza O, Lebrun-Vignes B, Mangone G, Vidailhet M, Charbonnier-Beaupel F, Rascol O, Lesage S, Brice A, Tezenas du Montcel S, Corvol JC; BADGE-PD study group.

Mov Disord. 2018 Dec;33(12):1878-1886. doi: 10.1002/mds.27519. Epub 2018 Nov 16.

PMID:
30444952
3.

Electroencephalography-based machine learning for cognitive profiling in Parkinson's disease: Preliminary results.

Betrouni N, Delval A, Chaton L, Defebvre L, Duits A, Moonen A, Leentjens AFG, Dujardin K.

Mov Disord. 2019 Feb;34(2):210-217. doi: 10.1002/mds.27528. Epub 2018 Oct 21.

PMID:
30345602
4.

Motor Preparation of Step Initiation: Error-related Cortical Oscillations.

Delval A, Braquet A, Dirhoussi N, Bayot M, Derambure P, Defebvre L, Tard C, Dujardin K.

Neuroscience. 2018 Nov 21;393:12-23. doi: 10.1016/j.neuroscience.2018.09.046. Epub 2018 Oct 10.

PMID:
30312784
5.

Dyspnea: An underestimated symptom in Parkinson's disease.

Baille G, Chenivesse C, Perez T, Machuron F, Dujardin K, Devos D, Defebvre L, Moreau C.

Parkinsonism Relat Disord. 2018 Sep 8. pii: S1353-8020(18)30386-9. doi: 10.1016/j.parkreldis.2018.09.001. [Epub ahead of print]

PMID:
30224267
6.

Erratum to « Ethical considerations and palliative care in patients with amyotrophic lateral sclerosis: A review » [Rev. Neurol. 173 (5) (2017) 300-307].

Danel-Brunaud V, Touzet L, Chevalier L, Moreau C, Devos D, Vandoolaeghe S, Defebvre L.

Rev Neurol (Paris). 2018 Jan - Feb;174(1-2):75. doi: 10.1016/j.neurol.2017.06.003. Epub 2018 Feb 4. No abstract available.

PMID:
29397085
7.

MRI of the cervical spinal cord predicts respiratory dysfunction in ALS.

Grolez G, Kyheng M, Lopes R, Moreau C, Timmerman K, Auger F, Kuchcinski G, Duhamel A, Jissendi-Tchofo P, Besson P, Laloux C, Petrault M, Devedjian JC, Pérez T, Pradat PF, Defebvre L, Bordet R, Danel-Brunaud V, Devos D.

Sci Rep. 2018 Jan 29;8(1):1828. doi: 10.1038/s41598-018-19938-2.

8.

Early occurrence of inspiratory muscle weakness in Parkinson's disease.

Baille G, Perez T, Devos D, Deken V, Defebvre L, Moreau C.

PLoS One. 2018 Jan 12;13(1):e0190400. doi: 10.1371/journal.pone.0190400. eCollection 2018.

9.

Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis?

Moreau C, Danel V, Devedjian JC, Grolez G, Timmerman K, Laloux C, Petrault M, Gouel F, Jonneaux A, Dutheil M, Lachaud C, Lopes R, Kuchcinski G, Auger F, Kyheng M, Duhamel A, Pérez T, Pradat PF, Blasco H, Veyrat-Durebex C, Corcia P, Oeckl P, Otto M, Dupuis L, Garçon G, Defebvre L, Cabantchik ZI, Duce J, Bordet R, Devos D.

Antioxid Redox Signal. 2018 Sep 10;29(8):742-748. doi: 10.1089/ars.2017.7493. Epub 2018 Feb 8.

10.

Use of a high-fidelity patient simulator for training 200 medical students in seizure management: A pilot study at the PRESAGE simulation center in Lille.

Moreau C, Delval A, Grolez G, Moulin S, Chen Y, Lebouvier T, Defebvre L, Poissy J, Jourdain M.

Rev Neurol (Paris). 2018 Jan - Feb;174(1-2):68-70. doi: 10.1016/j.neurol.2017.06.014. Epub 2017 Nov 13. No abstract available.

PMID:
29146115
11.

Writing tremor: Should we look for a TOR1A mutation?

Aerts C, Cassim F, Strubi-Vuillaume I, Destée A, Sablonnière B, Collod-Béroud G, Defebvre L, Kreisler A.

J Neurol Sci. 2017 Nov 15;382:146-147. doi: 10.1016/j.jns.2017.09.048. Epub 2017 Oct 2. No abstract available.

12.

Expanding the phenotype of SCA19/22: Parkinsonism, cognitive impairment and epilepsy.

Huin V, Strubi-Vuillaume I, Dujardin K, Brion M, Delliaux M, Dellacherie D, Cuvellier JC, Cuisset JM, Riquet A, Moreau C, Defebvre L, Sablonnière B, Devos D.

Parkinsonism Relat Disord. 2017 Dec;45:85-89. doi: 10.1016/j.parkreldis.2017.09.014. Epub 2017 Sep 19.

PMID:
28947073
13.

Freezing during tapping tasks in patients with advanced Parkinson's disease and freezing of gait.

Delval A, Defebvre L, Tard C.

PLoS One. 2017 Sep 8;12(9):e0181973. doi: 10.1371/journal.pone.0181973. eCollection 2017.

14.

New perspectives on study designs for evaluating neuroprotection in Parkinson's disease.

Thibault L, Rascol O, Corvol JC, Ferreira J, Defebvre L, Deplanque D, Bordet R, Moreau C, Devos D.

Mov Disord. 2017 Oct;32(10):1365-1370. doi: 10.1002/mds.27055. Epub 2017 Jul 13. No abstract available.

PMID:
28703395
15.

Levodopa has primarily negative influences on postural control in patients with Parkinson's disease.

Bonnet CT, Delval A, Szaffarczyk S, Defebvre L.

Behav Brain Res. 2017 Jul 28;331:67-75. doi: 10.1016/j.bbr.2017.05.033. Epub 2017 May 16.

PMID:
28526514
16.

Descriptive study of the parkinsonian population in the north of France: Epidemiological analysis and healthcare consumption.

Carriere N, Verloop D, Dupont C, Fontaine V, Tir M, Krystkowiak P, Blanchard A, Defebvre MM, Defebvre L.

Rev Neurol (Paris). 2017 Jun;173(6):396-405. doi: 10.1016/j.neurol.2017.03.036. Epub 2017 May 8.

PMID:
28495231
17.

Ethical considerations and palliative care in patients with amyotrophic lateral sclerosis: A review.

Danel-Brunaud V, Touzet L, Chevalier L, Moreau C, Devos D, Vandoolaeghe S, Defebvre L.

Rev Neurol (Paris). 2017 May;173(5):300-307. doi: 10.1016/j.neurol.2017.03.032. Epub 2017 May 4. Review. Erratum in: Rev Neurol (Paris). 2018 Jan 31;:.

PMID:
28479121
18.

Clinical features of amyotrophic lateral sclerosis and their prognostic value.

Tard C, Defebvre L, Moreau C, Devos D, Danel-Brunaud V.

Rev Neurol (Paris). 2017 May;173(5):263-272. doi: 10.1016/j.neurol.2017.03.029. Epub 2017 May 4. Review.

PMID:
28477850
19.

Functional connectivity disruptions correlate with cognitive phenotypes in Parkinson's disease.

Hassan M, Chaton L, Benquet P, Delval A, Leroy C, Plomhause L, Moonen AJ, Duits AA, Leentjens AF, van Kranen-Mastenbroek V, Defebvre L, Derambure P, Wendling F, Dujardin K.

Neuroimage Clin. 2017 Mar 6;14:591-601. doi: 10.1016/j.nicl.2017.03.002. eCollection 2017.

20.

[Medical and surgical treatment of Parkinson's disease].

Defebvre L, Moreau C.

Presse Med. 2017 Mar;46(2 Pt 1):218-224. doi: 10.1016/j.lpm.2017.01.018. Epub 2017 Mar 6. Review. French.

PMID:
28279509
21.

Cognitive phenotypes in parkinson's disease differ in terms of brain-network organization and connectivity.

Lopes R, Delmaire C, Defebvre L, Moonen AJ, Duits AA, Hofman P, Leentjens AF, Dujardin K.

Hum Brain Mapp. 2017 Mar;38(3):1604-1621. doi: 10.1002/hbm.23474. Epub 2016 Nov 17.

PMID:
27859960
22.

Hallucinations and conscious access to visual inputs in Parkinson's disease.

Lefebvre S, Baille G, Jardri R, Plomhause L, Szaffarczyk S, Defebvre L, Thomas P, Delmaire C, Pins D, Dujardin K.

Sci Rep. 2016 Nov 14;6:36284. doi: 10.1038/srep36284.

23.

Attention modulation during motor preparation in Parkinsonian freezers: A time-frequency EEG study.

Tard C, Dujardin K, Bourriez JL, Molaee-Ardekani B, Derambure P, Defebvre L, Delval A.

Clin Neurophysiol. 2016 Dec;127(12):3506-3515. doi: 10.1016/j.clinph.2016.09.014. Epub 2016 Oct 5.

PMID:
27815974
24.

RNA-binding disturbances as a continuum from spinocerebellar ataxia type 2 to Parkinson disease.

Nkiliza A, Mutez E, Simonin C, Leprêtre F, Duflot A, Figeac M, Villenet C, Semaille P, Comptdaer T, Genet A, Sablonnière B, Devos D, Defebvre L, Destée A, Chartier-Harlin MC.

Neurobiol Dis. 2016 Dec;96:312-322. doi: 10.1016/j.nbd.2016.09.014. Epub 2016 Sep 20.

PMID:
27663142
25.

Foreword.

Anheim M, Roze E, Defebvre L.

Rev Neurol (Paris). 2016 Aug - Sep;172(8-9):407. doi: 10.1016/j.neurol.2016.08.008. No abstract available.

PMID:
27692122
26.

Are Upper-Body Axial Symptoms a Feature of Early Parkinson's Disease?

Moreau C, Devos D, Baille G, Delval A, Tard C, Perez T, Danel-Buhl N, Seguy D, Labreuche J, Duhamel A, Delliaux M, Dujardin K, Defebvre L.

PLoS One. 2016 Sep 21;11(9):e0162904. doi: 10.1371/journal.pone.0162904. eCollection 2016.

27.

Freezing/festination during motor tasks in early-stage Parkinson's disease: A prospective study.

Delval A, Rambour M, Tard C, Dujardin K, Devos D, Bleuse S, Defebvre L, Moreau C.

Mov Disord. 2016 Dec;31(12):1837-1845. doi: 10.1002/mds.26762. Epub 2016 Sep 13.

PMID:
27618808
28.

The value of magnetic resonance imaging as a biomarker for amyotrophic lateral sclerosis: a systematic review.

Grolez G, Moreau C, Danel-Brunaud V, Delmaire C, Lopes R, Pradat PF, El Mendili MM, Defebvre L, Devos D.

BMC Neurol. 2016 Aug 27;16(1):155. doi: 10.1186/s12883-016-0672-6. Review.

29.

Movement disorders and stroke.

Defebvre L, Krystkowiak P.

Rev Neurol (Paris). 2016 Aug - Sep;172(8-9):483-487. doi: 10.1016/j.neurol.2016.07.006. Epub 2016 Jul 28. Review.

PMID:
27476417
30.

Impulse Control Disorders in Parkinson's Disease are Associated with Alterations in Reward-Related Cortical Oscillations.

Carriere N, Bourriez JL, Delval A, Derambure P, Defebvre L, Dujardin K.

J Parkinsons Dis. 2016 Jun 28;6(3):651-66. doi: 10.3233/JPD-160828.

PMID:
27372215
31.

Ventilatory Dysfunction in Parkinson's Disease.

Baille G, De Jesus AM, Perez T, Devos D, Dujardin K, Charley CM, Defebvre L, Moreau C.

J Parkinsons Dis. 2016 Jun 16;6(3):463-71. doi: 10.3233/JPD-160804. Review.

32.

Single session intermittent theta-burst stimulation on the left premotor cortex does not alleviate freezing of gait in Parkinson's disease.

Tard C, Devanne H, Defebvre L, Delval A.

Neurosci Lett. 2016 Aug 15;628:1-9. doi: 10.1016/j.neulet.2016.05.061. Epub 2016 Jun 3.

PMID:
27268039
33.

Randomized placebo-controlled trial of sodium valproate in progressive supranuclear palsy.

Leclair-Visonneau L, Rouaud T, Debilly B, Durif F, Houeto JL, Kreisler A, Defebvre L, Lamy E, Volteau C, Nguyen JM, Dily SL, Damier P, Boutoleau-Bretonnière C, Lejeune P, Derkinderen P.

Clin Neurol Neurosurg. 2016 Jul;146:35-9. doi: 10.1016/j.clineuro.2016.04.021. Epub 2016 Apr 27.

PMID:
27136096
34.

Quality of life in Parkinson's disease improved by apomorphine pump: the OPTIPUMP cohort study.

Drapier S, Eusebio A, Degos B, Vérin M, Durif F, Azulay JP, Viallet F, Rouaud T, Moreau C, Defebvre L, Fraix V, Tranchant C, Andre K, Courbon CB, Roze E, Devos D.

J Neurol. 2016 Jun;263(6):1111-9. doi: 10.1007/s00415-016-8106-3. Epub 2016 Apr 8.

PMID:
27060084
35.

Magnetic Resonance Imaging Features of the Nigrostriatal System: Biomarkers of Parkinson's Disease Stages?

Hopes L, Grolez G, Moreau C, Lopes R, Ryckewaert G, Carrière N, Auger F, Laloux C, Petrault M, Devedjian JC, Bordet R, Defebvre L, Jissendi P, Delmaire C, Devos D.

PLoS One. 2016 Apr 1;11(4):e0147947. doi: 10.1371/journal.pone.0147947. eCollection 2016.

36.

A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced Dyskinesia.

Trenkwalder C, Berg D, Rascol O, Eggert K, Ceballos-Baumann A, Corvol JC, Storch A, Zhang L, Azulay JP, Broussolle E, Defebvre L, Geny C, Gostkowski M, Stocchi F, Tranchant C, Derkinderen P, Durif F, Espay AJ, Feigin A, Houeto JL, Schwarz J, Di Paolo T, Feuerbach D, Hockey HU, Jaeger J, Jakab A, Johns D, Linazasoro G, Maruff P, Rozenberg I, Sovago J, Weiss M, Gomez-Mancilla B.

Mov Disord. 2016 Jul;31(7):1049-54. doi: 10.1002/mds.26569. Epub 2016 Mar 15.

PMID:
26990766
37.

Influence of repetitive transcranial magnetic stimulation on tibialis anterior activity during walking in humans.

Rambour M, Caux-Dedeystère A, Devanne H, Defebvre L, Derambure P, Delval A.

Neurosci Lett. 2016 Mar 11;616:49-56. doi: 10.1016/j.neulet.2016.01.027. Epub 2016 Jan 19.

PMID:
26806037
38.

Acetylcholinesterase inhibitors and gait: a steadying hand?

Moreau C, Devos D, Defebvre L.

Lancet Neurol. 2016 Mar;15(3):232-3. doi: 10.1016/S1474-4422(16)00003-X. Epub 2016 Jan 13. No abstract available.

39.

Characterization and quantification of freezing of gait in Parkinson's disease: Can detection algorithms replace clinical expert opinion?

Delval A, Tard C, Rambour M, Defebvre L, Moreau C.

Neurophysiol Clin. 2015 Nov;45(4-5):305-13. doi: 10.1016/j.neucli.2015.09.009. Epub 2015 Nov 5. Review.

PMID:
26547546
40.

Hypometabolism in Posterior and Temporal Areas of the Brain is Associated with Cognitive Decline in Parkinson's Disease.

Tard C, Demailly F, Delval A, Semah F, Defebvre L, Dujardin K, Moreau C.

J Parkinsons Dis. 2015;5(3):569-74. doi: 10.3233/JPD-150583.

PMID:
26406137
41.

How does visuospatial attention modulate motor preparation during gait initiation?

Tard C, Dujardin K, Girard A, Debaughrien M, Derambure P, Defebvre L, Delval A.

Exp Brain Res. 2016 Jan;234(1):39-50. doi: 10.1007/s00221-015-4436-0. Epub 2015 Sep 10.

PMID:
26358126
42.

Cognitive disorders in Parkinson's disease: Confirmation of a spectrum of severity.

Dujardin K, Moonen AJ, Behal H, Defebvre L, Duhamel A, Duits AA, Plomhause L, Tard C, Leentjens AF.

Parkinsonism Relat Disord. 2015 Nov;21(11):1299-305. doi: 10.1016/j.parkreldis.2015.08.032. Epub 2015 Aug 29.

PMID:
26350121
43.

Brain metabolic abnormalities during gait with freezing in Parkinson's disease.

Tard C, Delval A, Devos D, Lopes R, Lenfant P, Dujardin K, Hossein-Foucher C, Semah F, Duhamel A, Defebvre L, Le Jeune F, Moreau C.

Neuroscience. 2015 Oct 29;307:281-301. doi: 10.1016/j.neuroscience.2015.08.063. Epub 2015 Sep 1.

44.

Diagnosing dementia in multiple system atrophy by applying Movement Disorder Society diagnostic criteria for Parkinson's disease dementia.

Auzou N, Dujardin K, Biundo R, Foubert-Samier A, Barth C, Duval F, Tison F, Defebvre L, Antonini A, Meissner WG.

Parkinsonism Relat Disord. 2015 Oct;21(10):1273-7. doi: 10.1016/j.parkreldis.2015.08.013. Epub 2015 Aug 14.

PMID:
26305998
45.

Impaired Early Attentional Processes in Parkinson's Disease: A High-Resolution Event-Related Potentials Study.

Bocquillon P, Bourriez JL, Palmero-Soler E, Defebvre L, Derambure P, Dujardin K.

PLoS One. 2015 Jul 2;10(7):e0131654. doi: 10.1371/journal.pone.0131654. eCollection 2015.

46.

Ceruloplasmin activity and iron chelation treatment of patients with Parkinson's disease.

Grolez G, Moreau C, Sablonnière B, Garçon G, Devedjian JC, Meguig S, Gelé P, Delmaire C, Bordet R, Defebvre L, Cabantchik IZ, Devos D.

BMC Neurol. 2015 May 6;15:74. doi: 10.1186/s12883-015-0331-3.

47.

Impaired corticostriatal connectivity in impulse control disorders in Parkinson disease.

Carriere N, Lopes R, Defebvre L, Delmaire C, Dujardin K.

Neurology. 2015 May 26;84(21):2116-23. doi: 10.1212/WNL.0000000000001619. Epub 2015 Apr 29.

PMID:
25925985
48.

Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's disease.

Moreau C, Meguig S, Corvol JC, Labreuche J, Vasseur F, Duhamel A, Delval A, Bardyn T, Devedjian JC, Rouaix N, Petyt G, Brefel-Courbon C, Ory-Magne F, Guehl D, Eusebio A, Fraix V, Saulnier PJ, Lagha-Boukbiza O, Durif F, Faighel M, Giordana C, Drapier S, Maltête D, Tranchant C, Houeto JL, Debû B, Azulay JP, Tison F, Destée A, Vidailhet M, Rascol O, Dujardin K, Defebvre L, Bordet R, Sablonnière B, Devos D; Parkgait-II Study Group.

Brain. 2015 May;138(Pt 5):1271-83. doi: 10.1093/brain/awv063. Epub 2015 Mar 23.

49.

The significance of cortical cerebellar microbleeds and microinfarcts in neurodegenerative and cerebrovascular diseases. A post-mortem 7.0-tesla magnetic resonance study with neuropathological correlates.

De Reuck JL, Deramecourt V, Auger F, Durieux N, Cordonnier C, Devos D, Defebvre L, Moreau C, Capparos-Lefebvre D, Pasquier F, Leys D, Maurage CA, Bordet R.

Cerebrovasc Dis. 2015;39(2):138-43. doi: 10.1159/000371488. Epub 2015 Jan 31.

50.

Self-perceived and actual ability in the functional reach test in patients with Parkinson's disease.

Ryckewaert G, Luyat M, Rambour M, Tard C, Noël M, Defebvre L, Delval A.

Neurosci Lett. 2015 Mar 4;589:181-4. doi: 10.1016/j.neulet.2015.01.039. Epub 2015 Jan 16.

PMID:
25600856

Supplemental Content

Loading ...
Support Center